SIGN guideline for the management of patients with demetia

International Journal of Geriatric Psychiatry

Volumn 21, Issue 1, 2006, Pages 14-16

  Connelly, Peter J ^a   James, Roberta ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b SIGN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

ALZHEIMER DISEASE; CLINICAL PRACTICE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; DRUG USE; EVIDENCE BASED PRACTICE; FALLING; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; NATIONAL HEALTH SERVICE; NOTE; PAIN; PATIENT CARE; PEER REVIEW; PHYSICIAN; PRACTICE GUIDELINE; PUBLISHING;

ACADEMIES AND INSTITUTES; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; DEMENTIA; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES; SCOTLAND; TREATMENT OUTCOME;

EID: 31344478485     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1491     Document Type: Note

References (3)

1. Field M, Lohr K. 1990. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical Practice Guidelines: Directions for a New Program. National Academy Press, Washington, DC.
2. Guyatt G, Sackett D, Sinclair J, Hayward R, Cook D, Cook R. 1995. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 274: 1800-1804.
3. Scottish Intercollegiate Guidelines Network. 2001. A Guideline Developers' Handbook. SIGN Publication no.50. SIGN;2001: Edinburgh (last updated 2004).